221 related articles for article (PubMed ID: 23170936)
1. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.
Loughrey BV; McGinty A; Young IS; McCance DR; Powell LA
Clin Endocrinol (Oxf); 2013 Dec; 79(6):800-6. PubMed ID: 23170936
[TBL] [Abstract][Full Text] [Related]
2. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
3. Circulating Levels of the Adipokines Monocyte Chemotactic Protein-4 (MCP-4), Macrophage Inflammatory Protein-1β (MIP-1β), and Eotaxin-3 in Severe Obesity and Following Bariatric Surgery.
Gentili A; Zaibi MS; Alomar SY; De Vuono S; Ricci MA; Alaeddin A; Siepi D; Boni M; Vaudo G; Trayhurn P; Lupattelli G
Horm Metab Res; 2016 Dec; 48(12):847-853. PubMed ID: 27300476
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
[TBL] [Abstract][Full Text] [Related]
5. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
[TBL] [Abstract][Full Text] [Related]
6. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
[TBL] [Abstract][Full Text] [Related]
7. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
[TBL] [Abstract][Full Text] [Related]
8. The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
Takebayashi K; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Aso Y; Inukai T
Metabolism; 2005 Sep; 54(9):1225-9. PubMed ID: 16125534
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
10. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
11. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
[TBL] [Abstract][Full Text] [Related]
14. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effect of insulin infusion on chemokines and chemokine receptors.
Ghanim H; Korzeniewski K; Sia CL; Abuaysheh S; Lohano T; Chaudhuri A; Dandona P
Diabetes Care; 2010 May; 33(5):1103-8. PubMed ID: 20200310
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
Neumeier M; Bauer S; Brühl H; Eisinger K; Kopp A; Abke S; Walter R; Schäffler A; Buechler C
Cytokine; 2011 Dec; 56(3):573-80. PubMed ID: 21890375
[TBL] [Abstract][Full Text] [Related]
18. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.
Kaburagi Y; Shimada Y; Nagaoka T; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2001 Jul; 293(7):350-5. PubMed ID: 11550808
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses.
Mirjanic-Azaric B; Rizzo M; Sormaz L; Stojanovic D; Uletilovic S; Sodin-Semrl S; Lakota K; Artenjak A; Marc J; Cerne D
Clin Biochem; 2013 Oct; 46(15):1526-31. PubMed ID: 23792106
[TBL] [Abstract][Full Text] [Related]
20. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
